(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DE GLOMERULOPATIA POR C3 USANDO UM INIBIDOR DE C5A

ArquivadaInvention PatentPCT · US2021064350

Application data

Number

112023012484

Type

Invention Patent

Filing

12/20/2021

Publication

07/18/2023

PCT

US2021064350

Progress at the INPI

  1. Filing12/20/21
  2. Publication07/18/23
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/20/2021 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/18/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

CHEMOCENTRYX, INC.

US

See this company's full portfolio

Inventors

P. S. (pessoa física)

US

P. B. (pessoa física)

US

Technical data

Priority claims

US

63/128,397 · 12/21/2020

Abstract

TRATAMENTO DE GLOMERULOPATIA POR C3 USANDO UM INIBIDOR DE C5A São proporcionados métodos de tratamento de certas populações de pacientes humanos sofrendo de ou suscetíveis a glomerulopatia por C3, compreendendo administrar ao humano uma quantidade eficaz de um antagonista de C5aR.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/18/2025

RPI 2828

Arquivamento - Art. 33 da LPI

#11.1

12/31/2024

RPI 2817

Notificação de entrada na fase nacional - PCT

#1.3

07/18/2023

RPI 2741

Alteração de dados cadastrais

#1.1

07/04/2023

RPI 2739

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.